Verrica Pharmaceuticals (VRCA) Q2 2023 Earnings

8AugConfirmed
Nov 22
Q4 2022
Q1 2023
Q2 2023
-0.21
-0.14
-0.07
0

Details

Expected EPS
-0.21
Actual EPS
-0.21
Surprise EPS
0
Surprise Percent
+0%

Description

Verrica Pharmaceuticals (VRCA) has reported earnings of -0.21 per share for Q2 2023.

0 Comments

Share your thoughts